In 2019 China's healthcare import and export volume both saw an increase from the previous year, making a record high since 2011. Europe, Asia, and North America were China's top three trading partners. US continue to be China's top 1 trading partner followed by Germany, Japan, India, and Island. Overseas investment, M&A, license-in, and license-out all increased. Healthcare reform in China continued to unleash new market opportunities. The number of international registration and certification acquired by chinese companies are also on the rise.
China HealthCare Industry Report (2019)
Download • 4.37MB